A background in physiotherapy helps the Oxford-based researcher mix basic science with clinical work to better understand pain stemming from nerve compression.
Meet some of the people featured in the January 2018 issue of The Scientist.
Researchers map brain activity associated with a person’s anticipation of or direct confrontation with danger.
Immune-like cells in the central nervous system are now recognized as key participants in the creation and maintenance of persistent pain.
Since the mid-2000s, the voltage-gated sodium channel NaV1.7 has emerged as a promising target for a new class of analgesics.
The brain is activated differently when it’s contemplating, rather than directly facing, a threat.
The acute pain that results from injury or disease is very different from chronic pain.
Researchers find consistent behaviors and brain activity in an international study.
Researchers are beginning to tease apart the mechanisms underlying differences in how males and females respond to powerful painkillers.
The race to develop analgesic drugs that inhibit sodium channel NaV1.7 is revealing a complex sensory role for the protein.
The prominent researcher has been put on administrative leave pending an investigation into unspecified allegations.
The 20-year project calls into question the conventional wisdom about the role plants will play in mitigating future climate change.
The US Senate narrowly approved the politician, who does not have a science background.
Researchers deliver small interfering RNAs loaded into nanoparticles into the ears of adult guinea pigs to regenerate hair cells damaged by noise.
© 1986-2018 The Scientist
